Abilify

Abil·i·fy (ə-bilґĭ-fi) trademark for preparations of aripiprazole.

Medical dictionary. 2011.

Look at other dictionaries:

  • Abilify — Strukturformel Allgemeines Freiname Aripiprazol Andere Namen …   Deutsch Wikipedia

  • Abilify — Aripiprazole Aripiprazole Général Nom IUPAC 7 [4 [4 (2,3 dichlorophényl) piperazin 1 yl]butoxy] 3,4 dihydro 1H quinolin 2 one No CAS …   Wikipédia en Français

  • Aripiprazole — Systematic (IUPAC) name 7 {4 [4 (2,3 dichlorophenyl)piperazin 1 yl]butoxy} 3,4 dihydroquinolin 2(1H) one Clinical data Trade names …   Wikipedia

  • Aripiprazol — Strukturformel Allgemeines Freiname Aripiprazol Andere Namen …   Deutsch Wikipedia

  • 129722-12-9 — Aripiprazole Aripiprazole Général Nom IUPAC 7 [4 [4 (2,3 dichlorophényl) piperazin 1 yl]butoxy] 3,4 dihydro 1H quinolin 2 one No CAS …   Wikipédia en Français

  • Aripiprazole — Général Nom IUPAC 7 [4 [4 (2,3 dichlorophényl) piperazin 1 yl]butoxy] 3,4 dihydro 1H quinolin 2 one No CAS …   Wikipédia en Français

  • C23H27Cl2N3O2 — Aripiprazole Aripiprazole Général Nom IUPAC 7 [4 [4 (2,3 dichlorophényl) piperazin 1 yl]butoxy] 3,4 dihydro 1H quinolin 2 one No CAS …   Wikipédia en Français

  • Aripiprazol — Nombre (IUPAC) sistemático 7 [4 [4 (2,3 diclorofenil) piperazin 1 il]butoxi] 3,4 dihidro 1H quinolin 2 ona …   Wikipedia Español

  • Atypical antipsychotic — The atypical antipsychotics (also known as second generation antipsychotics) are a group of antipsychotic drugs used to treat psychiatric conditions. Some atypical antipsychotics are FDA approved for use in the treatment of schizophrenia. Some… …   Wikipedia

  • Antipsychotic — Advertisement for Thorazine (chlorpromazine) from the 1950s[1] An antipsychotic (or neuroleptic) is a tranquilizing psychiatric medication primarily used to manage psychosis (including delusions or hallucinations, as well as disordered tho …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”

We are using cookies for the best presentation of our site. Continuing to use this site, you agree with this.